[go: up one dir, main page]

MX9705916A - Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. - Google Patents

Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.

Info

Publication number
MX9705916A
MX9705916A MX9705916A MX9705916A MX9705916A MX 9705916 A MX9705916 A MX 9705916A MX 9705916 A MX9705916 A MX 9705916A MX 9705916 A MX9705916 A MX 9705916A MX 9705916 A MX9705916 A MX 9705916A
Authority
MX
Mexico
Prior art keywords
hiv
ddi
ddc
reverse transcriptase
azt
Prior art date
Application number
MX9705916A
Other languages
English (en)
Inventor
Jeffrey A Chodakewitz
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9705916A publication Critical patent/MX9705916A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La combinacion del Compuesto J, inhibidor de proteasa de VIH, 3TC, y, opcionalmente AZT, ddI, o ddC, es util en la inhibicion de proteasa de VIH, la inhibicion de trasncriptasa inversa de VIH, la prevencion o tratamiento de infeccion por VIH y el tratamiento de SIDA, ya sea como compuestos, sales farmacéuticamente aceptables o ingredientes de composicion farmacéutica, en combinacion o no con otros antivirales, inmunomoduladores, antibioticos o vacunas; también se describen métodos de tratamiento de SIDA y métodos de prevencion o tratamiento de la infeccion por VIH.
MX9705916A 1995-02-01 1996-01-29 Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. MX9705916A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection
PCT/US1996/001417 WO1996023509A1 (en) 1995-02-01 1996-01-29 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc

Publications (1)

Publication Number Publication Date
MX9705916A true MX9705916A (es) 1997-10-31

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705916A MX9705916A (es) 1995-02-01 1996-01-29 Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.

Country Status (38)

Country Link
US (1) US6689761B1 (es)
EP (1) EP0806957B1 (es)
JP (1) JPH10513186A (es)
KR (1) KR19980701856A (es)
CN (1) CN1160081C (es)
AR (1) AR002957A1 (es)
AT (1) ATE243519T1 (es)
AU (1) AU711176B2 (es)
BR (1) BR9607714A (es)
CA (1) CA2211973A1 (es)
CO (1) CO4700430A1 (es)
CZ (1) CZ244497A3 (es)
DE (1) DE69628819T2 (es)
DK (1) DK0806957T3 (es)
DZ (1) DZ1988A1 (es)
EA (1) EA000437B1 (es)
EE (1) EE03514B1 (es)
ES (1) ES2200052T3 (es)
FI (1) FI973184A (es)
HK (1) HK1004659A1 (es)
HR (1) HRP960045B1 (es)
HU (1) HUP9800810A3 (es)
IL (1) IL116925A (es)
IS (1) IS1970B (es)
MX (1) MX9705916A (es)
MY (1) MY121604A (es)
NO (1) NO314568B1 (es)
NZ (1) NZ302153A (es)
PE (1) PE38397A1 (es)
PL (1) PL182742B1 (es)
PT (1) PT806957E (es)
SA (1) SA96160669B1 (es)
SK (1) SK103797A3 (es)
TR (1) TR199700735T1 (es)
TW (1) TW442291B (es)
WO (1) WO1996023509A1 (es)
YU (1) YU49417B (es)
ZA (1) ZA96722B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942747A1 (en) * 1996-08-26 1999-09-22 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
WO1999060988A2 (en) * 1998-05-29 1999-12-02 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1814548A1 (en) * 2004-11-19 2007-08-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
CA2616592C (en) * 2005-07-27 2014-09-09 Emil Toma Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
US11116762B2 (en) * 2017-01-04 2021-09-14 Oyagen, Inc. Compounds, compositions, and methods for treating human immunodeficiency virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
CN1090186C (zh) 1993-03-31 2002-09-04 麦克公司 治疗aids药物组合物中的hiv蛋白酶抑制剂
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
DE69628819T2 (de) 2004-05-13
IS4533A (is) 1997-07-29
HUP9800810A2 (hu) 1998-07-28
NO314568B1 (no) 2003-04-14
SA96160669B1 (ar) 2006-07-30
NZ302153A (en) 1998-12-23
IS1970B (is) 2004-12-15
AR002957A1 (es) 1998-05-27
HK1004659A1 (en) 1998-12-04
SK103797A3 (en) 1998-02-04
CZ244497A3 (cs) 1998-01-14
EE03514B1 (et) 2001-10-15
BR9607714A (pt) 1998-01-13
EP0806957B1 (en) 2003-06-25
CN1179722A (zh) 1998-04-22
EP0806957A1 (en) 1997-11-19
ATE243519T1 (de) 2003-07-15
IL116925A (en) 2000-07-26
IL116925A0 (en) 1996-05-14
YU49417B (sh) 2006-01-16
HRP960045A2 (en) 1997-10-31
NO973533D0 (no) 1997-07-31
PL182742B1 (pl) 2002-02-28
FI973184A0 (fi) 1997-07-31
EA199700150A1 (ru) 1997-12-30
ES2200052T3 (es) 2004-03-01
HRP960045B1 (en) 2004-06-30
DE69628819D1 (de) 2003-07-31
MY121604A (en) 2006-02-28
AU711176B2 (en) 1999-10-07
YU6396A (sh) 1999-06-15
EA000437B1 (ru) 1999-08-26
ZA96722B (en) 1996-08-26
KR19980701856A (ko) 1998-06-25
FI973184A (fi) 1997-09-30
PE38397A1 (es) 1997-10-09
US6689761B1 (en) 2004-02-10
NO973533L (no) 1997-10-01
DZ1988A1 (fr) 2002-07-20
AU4774896A (en) 1996-08-21
WO1996023509A1 (en) 1996-08-08
CA2211973A1 (en) 1996-08-08
TR199700735T1 (xx) 1998-02-21
EE9700165A (et) 1998-02-16
JPH10513186A (ja) 1998-12-15
DK0806957T3 (da) 2003-09-29
TW442291B (en) 2001-06-23
CN1160081C (zh) 2004-08-04
PL321660A1 (en) 1997-12-22
CO4700430A1 (es) 1998-12-29
HUP9800810A3 (en) 2001-05-28
PT806957E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
AU2725392A (en) Hiv protease inhibitors
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
MY109834A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
EP0766674A4 (en) NOVEL HIV PROTEASE INHIBITORS
ZA9711606B (en) Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
PL314984A1 (en) Hiv protease inhibitors
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
WO1996000068A3 (en) Combination therapy for hiv infection
EP0774969B8 (en) Hiv protease inhibitor combination
TR200001938T2 (tr) AIDS tedavisi için kombinasyon terapisi.
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors
ECSP961660A (es) Terapia combinada para infeccion por vih

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees